NCT04541927View on ClinicalTrials.gov

Better Delineation of BCL11B Related Phenotype and Epigenetic Signature.

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Intellectual Developmental DisorderBCL11B Related Disorder
Interventions
GENETIC

Epigenetic signatures

Epigenetic signatures (Dr Sadikovic' lab, London, Ontario, Canada)

Trial Locations (1)

34295

UH Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04541927 - Better Delineation of BCL11B Related Phenotype and Epigenetic Signature. | Biotech Hunter | Biotech Hunter